Market niche Ocular Systems is a specialized ophthalmic biotech with a history of supplying prepared corneal tissue and instruments for specialized transplants, indicating strong domain expertise and potential partnerships with eye banks, hospitals, and surgical centers for expansion in corneal graft supply and instrument adoption.

Growth opportunity With a lean team and revenue under one million, there is potential for strategic channels focusing on hospital systems, academic centers, and high-volume ophthalmology networks to scale surgical solutions and tissue distribution.

Product leverage OSI’s EndoSerter Corneal Endothelium Delivery Instrument represents a differentiated offering; sales conversations can emphasize adoption by DSEK procedures and training programs to drive instrument sales alongside tissue supply.

Evidence-backed track Having delivered corneal tissue for over 20,000 transplants demonstrates credibility and reliability; emphasize this track record in proposals to procurement teams and risk-averse buyers seeking proven suppliers.

Strategic partnerships Potential collaborations with larger players in the corneal supply chain or investment firms could accelerate growth, expand geographic reach, and enhance dry-run capacity for tissue and instrument distribution.